Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Equity Ratio (2018 - 2025)

Historic Equity Ratio for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to 0.38.

  • TransMedics' Equity Ratio rose 4050.73% to 0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38, marking a year-over-year increase of 4050.73%. This contributed to the annual value of 0.28 for FY2024, which is 4630.46% up from last year.
  • TransMedics' Equity Ratio amounted to 0.38 in Q3 2025, which was up 4050.73% from 0.36 recorded in Q2 2025.
  • Over the past 5 years, TransMedics' Equity Ratio peaked at 0.68 during Q3 2022, and registered a low of 0.18 during Q3 2023.
  • Over the past 5 years, TransMedics' median Equity Ratio value was 0.38 (recorded in 2025), while the average stood at 0.42.
  • Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 7315.3% in 2023, then skyrocketed by 4630.46% in 2024.
  • TransMedics' Equity Ratio (Quarter) stood at 0.5 in 2021, then surged by 34.4% to 0.68 in 2022, then tumbled by 71.26% to 0.19 in 2023, then surged by 46.3% to 0.28 in 2024, then surged by 32.06% to 0.38 in 2025.
  • Its Equity Ratio was 0.38 in Q3 2025, compared to 0.36 in Q2 2025 and 0.32 in Q1 2025.